BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18685341)

  • 1. Variable interactions of recipient killer cell immunoglobulin-like receptors with self and allogenic human leukocyte antigen class I ligands may influence the outcome of solid organ transplants.
    Rajalingam R
    Curr Opin Organ Transplant; 2008 Aug; 13(4):430-7. PubMed ID: 18685341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation.
    Dupont B; Hsu KC
    Curr Opin Immunol; 2004 Oct; 16(5):634-43. PubMed ID: 15342011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
    Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
    Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Choi Y; Min WS; Kim TG; Cho BS; Kim SY; Eom KS; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim CC
    Transplantation; 2007 Nov; 84(9):1082-91. PubMed ID: 17998861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.
    Ruggeri L; Capanni M; Mancusi A; Martelli MF; Velardi A
    Transpl Immunol; 2005 Aug; 14(3-4):203-6. PubMed ID: 15982564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell activation in the lung allograft early posttransplantation.
    Meehan AC; Sullivan LC; Mifsud NA; Brooks AG; Snell GI; Kotsimbos TC; Westall GP
    Transplantation; 2010 Mar; 89(6):756-63. PubMed ID: 20019647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
    Hsu KC; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf EW
    Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.
    Moroso V; van der Meer A; Tilanus HW; Kazemier G; van der Laan LJ; Metselaar HJ; Joosten I; Kwekkeboom J
    Transpl Int; 2011 Sep; 24(9):932-42. PubMed ID: 21672051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products.
    Sivori S; Falco M; Moretta L; Moretta A
    Trends Immunol; 2010 Aug; 31(8):289-94. PubMed ID: 20630802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the killer cell immunoglobulin-like receptor system.
    Rajalingam R
    Methods Mol Biol; 2012; 882():391-414. PubMed ID: 22665247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
    Willemze R; Ruggeri A; Purtill D; Rodrigues CA; Gluckman E; Rocha V;
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):283-90. PubMed ID: 20837340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors that turn on and turn off natural killer cells.
    Chong AS
    J Heart Lung Transplant; 1996 Jul; 15(7):675-83. PubMed ID: 8820783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond ABO and human histocompatibility antigen: other histocompatibility antigens with a role in transplantation.
    Sumitran-Holgersson S
    Curr Opin Organ Transplant; 2008 Aug; 13(4):425-9. PubMed ID: 18685340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunobiology of natural killer cells and bone marrow allograft rejection.
    Barao I; Murphy WJ
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):727-41. PubMed ID: 14677112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
    Moretta A; Locatelli F; Moretta L
    Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Perruccio K; Aversa F; Martelli MF; Velardi A
    Semin Cancer Biol; 2006 Oct; 16(5):404-11. PubMed ID: 16916611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant.
    Velardi A; Ruggeri L; Mancusi A
    Curr Opin Hematol; 2012 Jul; 19(4):319-23. PubMed ID: 22555394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of KIRs and KIR ligands in hematopoietic transplantation.
    Velardi A
    Curr Opin Immunol; 2008 Oct; 20(5):581-7. PubMed ID: 18675345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants.
    De Santis D; Bishara A; Witt CS; Nagler A; Brautbar C; Slavin S; Christiansen FT
    Tissue Antigens; 2005 Jun; 65(6):519-28. PubMed ID: 15896199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.